Neurocrine Biosciences, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64125C1099
USD
182.83
6.42 (3.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryNeurocrine Biosciences, Inc. VS Pharmaceuticals & Biotechnology
 
1D
3.64%
0.21%
1W
2.11%
-1.07%
1M
8.49%
1.02%
YTD
28.91%
8.52%
1Y
36.74%
16.26%
3Y
77.94%
62.12%
5Y
94.67%
68.81%
10Y
264.57%
242.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
42.7%
0%
42.7%
6 Months
35.77%
0%
35.77%
1 Year
36.74%
0%
36.74%
2 Years
24.54%
0%
24.54%
3 Years
77.94%
0%
77.94%
4 Years
94.71%
0%
94.71%
5 Years
94.67%
0%
94.67%

Neurocrine Biosciences, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary